• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIANG Guangping, YANG Jun, WU Yunqiu, WAN Luping, RUAN Lijun, SONG Zhijun. Synthesis and anti-tumor activity of Z-Gly-Pro-OH-podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(1): 32-40. DOI: 10.11665/j.issn.1000-5048.20220105
Citation: LIANG Guangping, YANG Jun, WU Yunqiu, WAN Luping, RUAN Lijun, SONG Zhijun. Synthesis and anti-tumor activity of Z-Gly-Pro-OH-podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(1): 32-40. DOI: 10.11665/j.issn.1000-5048.20220105

Synthesis and anti-tumor activity of Z-Gly-Pro-OH-podophyllotoxin derivatives

Funds: This study was supported by Guizhou Vocational Education Quality Improvement Project (No. [2019]7) and the Science and Technology Project of Zunyi City (No. [2018]37)
More Information
  • Received Date: October 07, 2021
  • Revised Date: December 15, 2021
  • Ten novel podophyllotoxin derivatives (IIIa-IIIi and IV) were synthesized by three-step reactions using podophyllotoxin and N-benzyloxycarbonyl glycine-L-proline as raw material. The structures of the target compounds were confirmed by 1H NMR, 13C NMR and MS. MTT method was used to test anti-tumor activity of the target compounds on HepG2, THP-1, HeLa and MCF-7 cells. The results showed that all the target compounds had inhibitory activity against HepG2, THP-1, HeLa and MCF-7 cells, and the inhibitory activity of IIIa on HepG2 cells was the most prominent with an IC50 value of 0.58 nmol/L. The binding mode of compound IIIa and FAPα was studied by molecular docking. Compound IIIa could bind to multiple sites of FAPα enzyme.
  • [1]
    . Biomolecules,2021,11(4):603.
    [2]
    Han HW,Lin HY,He DL,et al. Novel podophyllotoxin derivatives as potential tubulin inhibitors:design,synthesis,and antiproliferative activity evaluation[J]. Chem Biodivers,2018,15(11):e1800289. doi:10.1002/cbdv.201800289.
    [3]
    Xu H,Lv M,Tian X. A review on hemisynthesis,biosynthesis,biological activities,mode of action,and structure-activity relationship of podophyllotoxins:2003-2007[J]. Curr Med Chem,2009,16(3):327-349.
    [4]
    Shi JF,Wei XY,Wu P,et al. Research progress on enzyme activated antitumor prodrugs based on FAP[J]. Drugs Clin(现代药物与临床),2019,34(10):3182-3186.
    [5]
    Garin-Chesa P,Old LJ,Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers[J]. Proc Natl Acad Sci U S A,1990,87(18):7235-7239.
    [6]
    Liu GQ. The study of pharmacodynamics and cardiotoxicity for a new targeting anti-tumor candidate compound Z-GP-EPI(新靶向抗肿瘤候选化合物Z-GP-EPI的药效学及心脏毒性考察)[D]. Guangzhou:Jinan University,2015.
    [7]
    Sun J,Yang D,Cui SH,et al. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation[J]. Int J Pharm,2019,559:48-57.
    [8]
    Deng LJ,Wang LH,Peng CK,et al. Fibroblast activation protein α activated tripeptide bufadienolide antitumor prodrug with reduced cardiotoxicity[J]. J Med Chem,2017,60(13):5320-5333.
    [9]
    Chai XP. Evaluation of anti-tumor efficacy of FAPaerfa5-activated prodrugs of BF211 in vitro and in vivo(FAPα激活式BF211系列前药的体内外抗肿瘤药效评价)[D]. Shanghai:East China Normal University,2017.
    [10]
    Zhang SJ,Zhu X,Xu YG. Study on structure-activity relationship of podophyllotoxin derivatives and ideas for the development of related new drugs[J]. Prog Pharm Sci(药学进展),2012,36(11):494-500.
    [11]
    Liang GP,Huang YM,Huang QZ,et al. Virtual design of FAPα-activated anti-tumor prodrug of podophyllotoxin[J]. Hans J Med Chem(药物化学),2021,9(2):28-34.
    [12]
    Zhang ZG,Zhang YH,Ji H,et al. Design,synthesis and antiasthmatic activities of NO-donatingseratrodast derivatives[J]. Acta Pharm Sin(药学学报),2004,39(9):705-710.
    [13]
    Zheng JH. Study on chemical constituents of Diphylleia sinensis Li.(窝儿七化学成分的研究)[D]. Xi''an:Shaanxi University of Science & Technology,2012.

Catalog

    Article views (242) PDF downloads (460) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return